0
Axonics Modulation Technologies, Inc. Banner Image

Axonics Modulation Technologies, Inc. has reached its limit for free report views

Work for Axonics Modulation Technologies, Inc.? Upgrade Your Profile and unlock all your annual reports.

Axonics Modulation Technologies, Inc.

  • Ticker AXNX
    Exchange NASDAQ More
  • Industry Medical Appliances & Equipment More
  • Sector Healthcare More
Axonics Modulation Technologies, Inc. Logo Image
  • 201-500 Employees
  • Based in Irvine, California
Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary and bowel dysfunction. These conditions are caused by a miscommunication between the bladder and the brain and significantly impacts quality of life. Overactive bladder affects an estimated 87 million adults in the U.S. and Europe. Another estimated 40 million adultsMore are reported to suffer from fecal incontinence/accidental bowel leakage. Axonics SNM therapy, which has been clinically proven to reduce symptoms and restore pelvic floor function, is now being offered at hundreds of medical centers across the U.S. and in dozens of select hospitals in Western Europe. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. The Axonics System is the first long-lived rechargeable SNM system approved for sale in the world, and the first to gain full-body MRI conditional labeling.
Axonics Modulation Technologies, Inc.

Most Recent Annual Report

Axonics Modulation Technologies, Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Axonics Modulation Technologies, Inc. has reached its limit for free report views.

Older/Archived Annual Reports